Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

Increasing life expectancy has led to an aging population, which has consequently increased the prevalence of dementia. Alzheimer's disease (AD), the most common form of dementia worldwide, is estimated to make up 50–80% of all cases. AD cases are expected to reach 131 million by 2050, and this...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Nanobiotechnology
Main Authors: Cano, Amanda, Turowski, Patric, Ettcheto, Miren, Duskey, Jason Thomas, Tosi, Giovanni, Sánchez-López, Elena, García, Maria Luisa, Camins, Antonio, Souto, Eliana B., Ruiz, Agustín, Marquié, Marta, Boada, Mercè
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8086346/
https://ncbi.nlm.nih.gov/pubmed/33926475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00864-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki